Created in 2018 (Belgium), Handl Therapeutics own 359 sister brands and 2214 competing brands. The Handl Therapeutics brand is owned by UCB, a company listed in Bruxelles. Its International Securities Identification Number (ISIN) is BE0003739530. Handl Therapeutics belongs to the Biotechnology business sector.